DNMT3A and acute myeloid leukemia: Additionally, miRNA-29b, down-regulates indirectly and directly DNMT1 and DNMT3A/3B expression respectively in AML patients [96] and along with miRNA-29a cooperatively target DNMT3A/3B expression in lung cancer [97], while they are both down-regulated in AML [98].